Microbiological Evaluation of the Efficacy of Water to Clean Tracheostomy Inner Cannulas
1 other identifier
interventional
60
1 country
1
Brief Summary
Biofilms pose a potential risk with reusable inner cannulas, by increasing the risk of infection. Effective decontamination is vital in eliminating these biofilms. An appropriate method of cleaning and decontamination to make inner cannula safe for reuse should be practiced. The current recommendations for cleaning inner cannula are varied with multiple techniques being put forth. The current practice of using sterile water to clean inner cannula is not supported by strong evidence. This Randomized Controlled Study looks into the microbiological efficacy of sterile water in cleaning inner cannulas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 30, 2017
CompletedFirst Submitted
Initial submission to the registry
September 8, 2020
CompletedFirst Posted
Study publicly available on registry
September 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 16, 2020
CompletedSeptember 25, 2020
September 1, 2020
3.6 years
September 8, 2020
September 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Efficacy of water vs detergent in cleaning tracheostomy inner cannulas
Compare the colony forming units / ml before and after cleaning with water vs detergent
1 week
Secondary Outcomes (2)
Economic evaluation
2 years
Microbiological evaluation
2 weeks
Study Arms (2)
AB (Detergent (A) followed by sterile water (B))
EXPERIMENTALSequence: Detergent (A) followed by sterile water (B) The inner cannula will be cleaned with commercially available tracheostomy cleaning fluid / powder (Ex: Trachoe - Kapitex healthcare, UK) in the first visit, and then cleaned with sterile water in the second visit, at a minimum period of 24 hrs apart. Laboratory analysis of colony counts will be conducted on the saline flushing pre- and post-decontamination for each washing.
BA (Sterile water (B) followed by detergent (A))
EXPERIMENTALSequence: Sterile water (B) followed by detergent (A) The inner cannula will be cleaned with sterile water in the first visit, and then cleaned with commercially available tracheostomy cleaning fluid / powder (Ex: Trachoe - Kapitex healthcare, UK) in the second visit, at a minimum period of 24 hrs apart. Laboratory analysis of colony counts will be conducted on the saline flushing pre- and post-decontamination for each washing.
Interventions
The tracheostomy inner cannulas will be washed with detergent.
The tracheostomy inner cannulas will be washed with sterile water.
Eligibility Criteria
You may qualify if:
- Patients aged between 21 - 100 years
- Patients with a tracheostomy tube in situ
You may not qualify if:
- Pregnant women
- Prisoners
- Patients with documented HIV, Hep C, Hep B
- Patients with active tuberculosis
- Patients being treated in Intensive Care Units
- Patients with ongoing antibiotic treatment or within the last 24 hours
- Unstable patients needing cardiorespiratory support
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Trials & Research Unit
Singapore, 529889, Singapore
Related Publications (1)
Bjorling G, Belin AL, Hellstrom C, Schedin U, Ransjo U, Alenius M, Johansson UB. Tracheostomy inner cannula care: a randomized crossover study of two decontamination procedures. Am J Infect Control. 2007 Nov;35(9):600-5. doi: 10.1016/j.ajic.2006.11.006.
PMID: 17980239BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hong Eng Chan
Changi General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Eligible patients will be randomized in 1:1 fashion using permuted blocks with different block sizes. The subjects and lab operators will be blinded to the block size and randomization. In the event unmasking need to be performed, a staff who is not involved in this study from Clinical Trial Unit will perform the unmasking.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Nurse Clinician
Study Record Dates
First Submitted
September 8, 2020
First Posted
September 25, 2020
Study Start
March 30, 2017
Primary Completion
November 16, 2020
Study Completion
November 16, 2020
Last Updated
September 25, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share